Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Pulse Biosciences Inc shares valued at $85,600 were purchased by Barrett Burke Thomas on May 20 ’24. At $8.56 per share, Barrett Burke Thomas acquired 10,000 shares. The insider’s holdings grew to 10,000 shares worth approximately $0.17 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, DUGGAN ROBERT W purchased 17,999 shares, netting a total of over 164,691 in proceeds. Following the buying of shares at $9.15 each, the insider now holds 36,984,179 shares.
Before that, DUGGAN ROBERT W had added 90,118 shares to its account. In a trade valued at $843,504, the Director bought Pulse Biosciences Inc shares for $9.36 each. Upon closing the transaction, the insider’s holdings increased to 90,118 shares, worth approximately $642.84 million.
As published in their initiating research note from Stephens on July 27, 2021, Pulse Biosciences Inc [PLSE] has been an Overweight and the price target has been revised to $28. Analysts at Maxim Group started covering the stock with ‘”a Buy”‘ outlook in a report released in mid March. As of January 26, 2021, H.C. Wainwright has reiterated its “Buy” rating for PLSE. Earlier on May 12, 2020, H.C. Wainwright upgraded its rating. Their new recommendation was “a Buy” for PLSE stock which previously was a “a Neutral”.
Analyzing PLSE Stock Performance
During the last five days, there has been a drop of approximately -3.66%. Over the course of the year, Pulse Biosciences Inc shares have jumped approximately 42.08%. Shares of the company reached a 52-week high of $22.69 on 08/23/24 and a 52-week low of $6.59 on 04/25/24. A 50-day SMA is recorded $17.36, while a 200-day SMA reached $13.06. Nevertheless, trading volume fell to 0.84 million shares from 0.31 million shares the previous day.
Support And Resistance Levels for Pulse Biosciences Inc (PLSE)
According to the 24-hour chart, there is a support level at 16.96, which, if violated, would cause prices to drop to 16.52. In the upper region, resistance lies at 18.11. The next price resistance is at 18.83. RSI (Relative Strength Index) is 49.97 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.58, which suggests the price will decrease in the coming days. Percent R is at 45.23%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Which companies own the most shares of Pulse Biosciences Inc (PLSE)?
On February 14, 2020, H.C. Wainwright assigned a price target of “a Neutral” to the stock and downgraded coverage with a $6.
